License To CRISPR IP To Be Offered By Merck & Broad Institute The
Broad Institute of MIT Harvard and Merck have agreed to a framework
through which they will offer non-exclusive licenses to CRISPR IP for
use in commercial research and product development – an initiative to
promote innovation. Under this agreement – Company using […]
The post Merck, Broad Institute To Offer Non-Exclusive License To
CRISPR IP appeared first on BioTecNika.
https://www.biotecnika.org/2019/07/license-to-crispr-ip-to-be-offered-by-merck-broad-institute/
Biotech News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment